Fibulin-1 is a component of the extracellular matrix that surrounds va
scular smooth muscle. This observation, along with the recent finding
that fibulin-1 can bind fibrinogen (J Biol Chem 270:19458, 1995), prom
pted investigation into the potential role of fibulin-1 as a thromboge
nic agent. In perfusion chamber assays, platelets in whole blood under
flow conditions attached and spread on surfaces coated with fibulin-1
. This adhesion was completely blocked by fibulin-1 antibodies. Platel
ets free of plasma did not attach to fibulin-1 coated surfaces; howeve
r, with the addition of fibrinogen, platelet adhesion to fibulin-1 too
k place. When detergent extracts of platelets were subjected to fibuli
n-1-Sepharose affinity chromatography, the integrin alpha(IIb)beta(3)
was selected. Solid phase binding assays using purified components sho
wed that integrin alpha(IIb)beta(3) could not bind directly to fibulin
-1 but in the presence of fibrinogen the integrin bound to fibulin-1-c
oated surfaces. Monoclonal alpha(IIb)beta(3), antibodies capable of bl
ocking its interaction with fibrinogen completely blocked platelet adh
esion to fibulin-1 in both whole blood perfusion and static adhesion a
ssays. The results show that fibulin-1 can support platelet attachment
via a bridge of fibrinogen to the platelet integrin alpha(IIb)beta(3)
. When fibroblast monolayers containing extracellular matrix-incorpora
ted fibulin-1 were used as adhesion substrates, platelet adhesion in t
he presence of fibrinogen could be inhibited by 30% using antibodies t
o fibulin-1. Following vascular injury, fibulin-1 present in the extra
cellular matrix of the vessel wall may therefore interact with plasma
fibrinogen and promote platelet adhesion, leading to the formation of
a platelet plug. Thus, fibulin-1 joins the list of matrix proteins inc
luding collagens I and IV and fibronectin that mediate platelet adhesi
on via a plasma protein bridge. This bridging phenomenon may represent
a general mechanism by which platelets interact with exposed subendot
helial matrices following vascular injury. (C) 1996 by The American So
ciety of Hematology.